Skip to main content
. 2024 Nov 8;16(11):1426. doi: 10.3390/pharmaceutics16111426

Figure 9.

Figure 9

Occlusion potential. The @ denotes the significant difference (p < 0.05) between formulations and their respective blank forms (F2-KC-AO versusF6-KC-B, and F4-KC-BO versus F6-KC-B); # represents the significant difference (p < 0.05) between polysaccharides (F5-GG-B versus F6-KC-B). NS means “not significant”. Similar occlusion potential was observed among the formulations. Data also suggests that the oily components may negatively affect the KC formulations.